Member Info for jdt1990

https://twitter.com/GoldstoneRes/status/1368886268285882369

Christ you are still at it Mumbo Jumbo. I am sure AS is far more in the detail and in conversations with the DHSC/Govt/PD about what is of concern and what the test needs to do. Leave the science to the professionals and tbh I would give up this stupid shorting/deramping game too.

The writings on the wall numpty

"I really don't get it. Any significant revenue received to Vela from any investment just gets re-invested almost instantly"

Mysteryguy - It's a very simple concept called compounding. Google will enlighten you.
Reinvest gains so the % gains on the next investment are larger in $ terms. Then growth is exponential from there, assuming you don't invest in a dog share and lose money.

As an investor here you should be pleased this is the approach being taken. Profits being re-invested is a hell of a lot better than JN running to the market for a placing every time he finds something new.

Or is AS hinting with this sentence that this tech will not just be applicable for Covid but a blueprint for other future viruses? i.e. yes its "late" but we have the framework for a virus detecting LFT and we are pretty confident what ever the next virus is "we have an Affimer for that". Simply insert and produce in scale.

"and indeed in response to any other future pandemic virus."

Now that we have developed a robust lateral flow test architecture, we can easily insert Affimer reagents that that can be very rapidly developed for new variants if necessary, and indeed in response to any other future pandemic virus.

This is the bit for me.....says we’re going global and have future proofed the product. No matter what strain around the world, simply insert the relevant Affimer. Oh and who makes the Affimer?
GENIUS!

“Now that we have developed a robust lateral flow test architecture, we can easily insert Affimer reagents that that can be very rapidly developed for new variants if necessary, and indeed in response to any other future pandemic virus.”

All this debate around GFC2 / financial Armageddon / buying coins to save yourself / were going to buying milk with wheelbarrows full of cash when hyperinflation hits.

Quite simply we have a huge asset in HAV with a mine life of 25 years plus. And it’s size is growing. POG is going to do all sorts in that time.
However, as GH and Sandeep have both made clear (and Cadia is a prime example of this), don’t underestimate the value of copper. That protects us from POG fluctuations to some extent.

So yes if it goes to $5000 / $10,000 happy days (as a shareholder not for the general catastrophe a GFC2 would cause)

But - if POG drops to $1400 / $1200, the assets is still hugely undervalued, and still open in multiple directions and at depth. That’s without another find across all the GGP tenements.

Bump to this Energyshares. A real eye opener for the one dimensional people hanging on to the LFT “all or nothing” rhetoric.
And the comical thing is only a couple of those are partially priced in and the rest have zero value as it stands.
The potential here is astronomical. Business model so scalable and if Affimers get their moment in the limelight with a gold standard LFT they will be queueing out the door.
Then there’s the therapeutics.
It just takes one....yes one of those to hit....hurts my head to think what could happen if 5....10.....15 of them do!!

Oooh change of tac now. Straight up testing wont be needed......I'd do some homework on that one.

What's next on the troll flow chart?

16th Feb
"These data from the first clinical studies will allow us to quickly progress with confidence into the full clinical validation of the test, manufactured at scale, at our clinical trial sites in the UK and the EU."

"On the basis of these excellent initial data, the Company will now progress to a full clinical validation with a larger number of patient samples to CE mark the test for professional use, aiming to bring the test to market in Europe around the end of the first quarter of this year."

So already 3 weeks into larger scale clinical validation. Tender doesn't close for another 4 and a half weeks. So what if it's not validated right now.
PD have also suggested they will accept validation from outside of PD (funny that, AVCT have it on the go in 2 sites.)

So, if S&S is as good in the larger CV sample size then it is absolutely a goer.

You can apply to a tender right up until deadline day - not sure if you grasped that? Hmmm end of the quarter a CE marked test. That's end of March....a week before end of tender date.

Come on - pull the other one

Just stinks of TW sending his goons out Sunday ready for a big couple of weeks ahead.

My response now to any of this cr*p is just two words. VOX INTERVIEW.

Jog on

Tom? Tom W? Is that you?

Eddo I assume that was sarcasm and you're talking about Turkeys vast array of discount procedures including the fames butt lifts for Instagram influencers and knock off hair transplants for middle aged men that Elton would be proud of?

Another cracking find Poirot.....

Was just looking back at the exclusivity arrangement with Medusa too. (Assuming this still stands?) Direct to consumers was exclusive but the workforce testing rights were not exclusive. So we could well be seeing more distribution agreements for the distribution to businesses.

For me AS has played a blinder. Avenues open in all the biggest markets and hasn't pigeon holed himself into one distributor or banked on one client (i.e. UK Govt). Direct to consumer market was always going to be the smallest so let them have that. Whatever that production number is, could well be queues out the door to be able to sell it!

"The Group has agreed an exclusive distribution agreement with Medusa19 for the supply of the COVID-19 rapid test direct to consumers globally, subject to the necessary regulatory approvals. Medusa19 has been established by Richard Hughes and Mahmud Kamani, both founder shareholders of Boohoo.com and shareholders of Avacta1, to build a global consumer self-testing business. Medusa19's initial focus will be on COVID-19 home testing and it is currently investing in global e-commerce, logistics and customer support infrastructure in preparation for Avacta's COVID-19 test launch. Medusa19 will also have non-exclusive rights to supply the tests to businesses for workforce testing. The distribution agreement includes a profit-sharing arrangement.."

nighteye. It’s was the exposure to her beloved Bitcoin investments that brought Melissa here. Then when JN sold BlockchainK2 exposure and didn’t plough every spare penny into KR1 and others in the crypto rush she had a bit of a meltdown and decided JN was incapable and she could run the company better.
Roll on 0.2p and good riddance.
ATB with your crypto investments though you’ll do well. I’m happy to let JN do the decision marking here though given his form!

Sod Boris! If this $1.9 trillion dollar relief bill gets passed through the house, that’s a big old cheque for tests!
“ Money for Covid-19 tests and vaccines
Mr Biden has called for devoting $50bn to improve testing centres and another $20bn to develop a national vaccination campaign, including setting up community centres and hiring new workers to administer the shots.
"We cannot rescue our economy without first containing the virus," Democrats said as they advanced the plans.

Crocqman. I think the £48m cash from the business update would suggest there is bottom line cash flow coming into AVCT.
It’s not that transparent where from exactly given the numbers behind the deals are kept under wraps being commercially sensitive.
However, some are just too blind to see beyond LFTs.....

And that’s just a tender for the first year, UK only!!. Testing going to be around for a lot longer than 12 months! Of course won’t be that size long term but still - cash in the bank is cash in the bank

Ah Jaylarc & Penny - that makes total sense!

JVTech -
https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/protocol-for-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices
Just to be clear PD's protocol has always been spiked samples in phase 2 and then real human samples in phase 3.
The puzzle is why PD didn't put AVCT through to phase 3 for those human samples. Clearly AS wasnt happy with that decision so decided to go to Europe and skip the bulls*it red tape process at PD

So no brain OR tonsil ticklers anymore! Which is interesting as the initial bidstats tenders did say specifically Nasopharyngeal was no longer being accepted and now Oropharyngeal has gone too. Could they be happy with developments in the AN space? hmmm

Nasopharyngeal Definition
A nasopharyngeal swab is one of the swabs used in COVID-19 testing and is designed to reach far back to your nasopharynx, an anatomical term that you may not have heard before. Your nasopharynx is part of the musculature that makes up your throat and nasal cavities, the pharynx. More specifically, the nasopharynx is behind your nose but above the soft palate of your mouth.

When used to collect a sample for a coronavirus test, a nasopharyngeal swab is inserted through the nasal passage all the way to the back of your throat. The process is fast, but may cause some minimal discomfort.

Oropharyngeal Definition
An orophayngeal swab is designed to reach your oropharynx, another part of the pharynx. Your ororpharynx is located below your nasopharynx; at the back of your throat and below the nasal passage openings.

When used to collect samples for COVID-19 or other coronaivurses, an orophayngeal swab is inserted via the mouth to the back of the throat. Some people find this a more comfortable and preferred method than the nasopharyngeal swab alternative.